Stockreport

Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™ and Approved Topical Minocycline Products in Greater China

MENLO THERAPEUTICS INC COMMON  (MNLO) 
Last menlo therapeutics inc common earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.menlotherapeutics.com/investor-relations
PDF BRIDGEWATER, N.J., April 23, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on [Read more]